drugset / Trial / NCT02501564

Evaluation of NaproxenSodium and CodeinePhosphate Combination in Osteoarthritis

NCT02501564

RandomizedParallel-groupDouble-blindTreatment

Summary

Osteoarthritis (OA) pain treatment has limitations in terms of serious adverse effects and low efficacy. The investigators aimed to evaluate efficacy and safety of naproxen sodium/codeine phosphate combination in these patients.

Timeline

Start
2013-05
Primary completion
2014-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Codeine Small molecule 30 mg Oral
Subject Naproxen Small molecule 550 mg Oral

Indications